March 2, 2020 / 1:57 PM / a month ago

BRIEF-Helius Medical Technologies Q4 Preliminary Revenue About $0.1 Mln

March 2 (Reuters) - Helius Medical Technologies Inc :

* HELIUS MEDICAL TECHNOLOGIES - PRELIMINARY REVENUE FOR Q4 OF 2019 WAS ABOUT $0.1 MILLION

* HELIUS MEDICAL - ON FEB 27, SUBMITTED CANADIAN CLASS II LICENSE AMENDMENT APPLICATION FOR TREATMENT OF GAIT DEFICIT IN PATIENTS WITH MILD & MODERATE MS

* HELIUS MEDICAL TECHNOLOGIES - EXPECTS TBI-002 TRIAL TO COST $6 MILLION & TO BEGIN ENROLLMENT IN APRIL 2020, TARGETING SUBMISSION TO FDA IN Q2 OF 2021 Source text: (here) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below